Airways Eosinophils as Antigen-presenting Cells in Asthma
气道嗜酸性粒细胞作为哮喘中的抗原呈递细胞
基本信息
- 批准号:7921759
- 负责人:
- 金额:$ 29.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-17 至 2011-09-16
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAllergensAllergicAntibodiesAntigen PresentationAntigen-Presenting CellsAntigensAsthmaB-LymphocytesBronchoalveolar LavageCell CommunicationCell physiologyCellsCessation of lifeChronicCytoplasmic GranulesDendritic CellsDiseaseEicosanoidsElectron MicroscopyEotaxinErythrocytesFc ReceptorHen Egg LysozymeHumanIgEIgG ReceptorsImmuneImmunizationImmunoglobulin AImmunoglobulin GInflammationInflammation MediatorsKnock-outLeukocytesLeukotriene C4LigandsLungLymphocyteLymphocyte antigen CD50LymphoidLymphoid CellLymphoid TissueMHC Class II GenesMediatingMediationMusMyelogenousNatureOrganOvalbuminParatrachealParticipantProcessProteinsPublic HealthReceptors, Antigen, B-CellRecruitment ActivityRegulationResearchRespiratory SystemRespiratory tract structureRoleSLAM proteinSiteSpleenSputumStagingStructure of thyroid parafollicular cellSynapsesT-Cell ReceptorT-LymphocyteTSLP geneTestingThymus GlandTransgenic OrganismsTransport Processallergic airway diseasealuminum sulfatebasecysteinyl-leukotrienecytokineeosinophileosinophil peroxidasegastrointestinalhuman TSLP proteinin vivoinsightintraperitoneallymph nodesnovelparacrineprogramspublic health relevancereceptorresponsetrafficking
项目摘要
DESCRIPTION (provided by applicant): Studies will investigate capabilities and mechanisms whereby eosinophils, including those recruited within airways in asthma, function as antigen-presenting cells that are of importance in propagating or modulating varied lymphocyte-dependent responses to respiratory tract encountered antigens. As antigen-presenting cells, eosinophils have distinct capabilities: First, airway eosinophils express requisite Class II MHC and lymphocyte costimulatory proteins. Second, eosinophils, like dendritic cells, function as "professional" antigen-presenting cells in expressing lymphocyte costimulatory proteins and activating unsensitized, naive T cells. Third, eosinophils, in contrast to other antigen-presenting cells, contain preformed stores of diverse cytokines that can be rapidly and selectively secreted to modulate varied lymphocyte responses. Fourth, eosinophils, like other antigen-presenting cells, utilize Fc receptor- mediated mechanisms to enhance antigen presentation by antigen-presenting cells. Eosinophil IgE, IgA and IgG receptors, together with airway allergen-specific IgE, IgA and IgG antibodies, can effectively present allergens. Fifth, airway eosinophils traffick into lymph nodes, spleen and even the thymus enabling airway antigens to be processed and transported into regional and systemic lymphoid tissues for presentation to varied lymphocytes. Sixth, eosinophils express ligands and receptors classically associated with dendritic cells, including DC-SIGN. Moreover, eosinophils can modulate B lymphocyte responses since eosinophils are critical participants in alum immunization-mediated B cell priming. Hypotheses to be tested are: that eosinophils trafficking from the airways are effective at presenting antigens to regulate, potentially differing, T lymphocyte responses in both regional and systemic lymphoid cells; that selective, restricted secretion of eosinophil cytokines mediates differential regulation of eosinophil antigen-presenting cell functions; and that eosinophils have roles in mediating the priming and responsiveness of B cells. Studies aim to investigate mechanisms by which eosinophils traffic and function as antigen-presenting cells to regulate regional and systemic T cell responses; eosinophil cytokines function in differential mediation of eosinophil antigen-presenting cell functions, and eosinophils function in B cell priming and activation. Roles for eosinophils as antigen-presenting cells in mediating allergic responses to airway antigens would provide novel insights into the characteristically chronic nature of asthma and other allergic airway diseases. PUBLIC HEALTH RELEVANCE. Asthma is an increasingly prevalent disease and a major public health problem. The research will help in understanding mechanisms that contribute to making asthma a chronic and persistent disease.
描述(由申请人提供):研究将调查嗜酸性粒细胞(包括哮喘气道内招募的嗜酸性粒细胞)作为抗原呈递细胞发挥作用的能力和机制,这些细胞对于传播或调节对呼吸道遇到的抗原的各种淋巴细胞依赖性反应至关重要。作为抗原呈递细胞,嗜酸性粒细胞具有独特的功能:首先,气道嗜酸性粒细胞表达必需的 II 类 MHC 和淋巴细胞共刺激蛋白。其次,嗜酸性粒细胞与树突状细胞一样,在表达淋巴细胞共刺激蛋白和激活未致敏的初始 T 细胞方面充当“专业”抗原呈递细胞。第三,与其他抗原呈递细胞相比,嗜酸性粒细胞含有预先储存的多种细胞因子,可以快速、选择性地分泌这些细胞因子来调节不同的淋巴细胞反应。第四,嗜酸性粒细胞与其他抗原呈递细胞一样,利用Fc受体介导的机制来增强抗原呈递细胞的抗原呈递。嗜酸性粒细胞IgE、IgA和IgG受体与气道过敏原特异性IgE、IgA和IgG抗体一起可以有效呈递过敏原。第五,气道嗜酸性粒细胞流入淋巴结、脾脏甚至胸腺,使气道抗原能够被加工并转运到区域和全身淋巴组织中,以呈递给各种淋巴细胞。第六,嗜酸性粒细胞表达通常与树突状细胞相关的配体和受体,包括DC-SIGN。此外,嗜酸性粒细胞可以调节 B 淋巴细胞反应,因为嗜酸性粒细胞是明矾免疫介导的 B 细胞启动的关键参与者。需要测试的假设是:来自气道的嗜酸性粒细胞能够有效地呈递抗原,以调节区域和全身淋巴细胞中可能存在差异的 T 淋巴细胞反应;嗜酸性粒细胞细胞因子的选择性、限制性分泌介导嗜酸性粒细胞抗原呈递细胞功能的差异调节;嗜酸性粒细胞在介导 B 细胞的启动和反应中发挥作用。研究旨在调查嗜酸性粒细胞作为抗原呈递细胞运输和发挥作用以调节区域和全身 T 细胞反应的机制;嗜酸性粒细胞细胞因子在嗜酸性粒细胞抗原呈递细胞功能的差异介导中发挥作用,而嗜酸性粒细胞在B细胞启动和激活中发挥作用。嗜酸性粒细胞作为抗原呈递细胞在介导气道抗原过敏反应中的作用将为了解哮喘和其他过敏性气道疾病的慢性特征提供新的见解。公共卫生相关性。哮喘是一种日益流行的疾病,也是一个重大的公共卫生问题。该研究将有助于了解导致哮喘成为慢性持续性疾病的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER F WELLER其他文献
PETER F WELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER F WELLER', 18)}}的其他基金
MULTI-LASER FLOW CYTOMETER: LUNG, AIRWAY & ALLERGIC INFLAMMATION
多激光流式细胞仪:肺、气道
- 批准号:
6973416 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
MULTI-LASER FLOW CYTOMETER: INFECTIOUS DIS, HERPE VIRUS, HCV
多激光流式细胞仪:传染性 DIS、疱疹病毒、HCV
- 批准号:
6973417 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
MULTI-LASER FLOW CYTOMETER: CANCER: BREAST, PROSTATE
多激光流式细胞仪:癌症:乳腺癌、前列腺癌
- 批准号:
6973415 - 财政年份:2004
- 资助金额:
$ 29.12万 - 项目类别:
Eosinophil Lipid Bodies in Allergic Inflammation
过敏性炎症中的嗜酸性粒细胞脂质体
- 批准号:
6480631 - 财政年份:2002
- 资助金额:
$ 29.12万 - 项目类别:
相似国自然基金
鱼类过敏原小清蛋白广谱性模拟抗原的精准构筑及构效关系研究
- 批准号:32372439
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
白色念珠菌过敏原通过CGRP-IL-21-PIEZO1轴促进T细胞-小胶质细胞-神经元通讯介导瘙痒
- 批准号:82371797
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
过敏原特异性Th2记忆前体细胞鉴定及其形成机制研究
- 批准号:82371740
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于酶联吸附反应的阵列式微流控传感芯片在即时场景气溶胶介质中对多重食物过敏原识别与检测的应用研究
- 批准号:32302231
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
过敏原RNA疫苗促进过敏性鼻炎中嗜酸性粒细胞分泌保护素D1诱导Treg产生机制
- 批准号:82371122
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Do allergens contribute to neurodegeneration?
过敏原会导致神经退行性变吗?
- 批准号:
10190052 - 财政年份:2021
- 资助金额:
$ 29.12万 - 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
- 批准号:
10495267 - 财政年份:2021
- 资助金额:
$ 29.12万 - 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
- 批准号:
10373575 - 财政年份:2021
- 资助金额:
$ 29.12万 - 项目类别: